Arformoterol Tartrate Solution
Product Images NDC 70756-612

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 70756-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 01)

Chemical structure of arformoterol tartrate, showing the molecular arrangement of its components including the arformoterol base and the tartrate salt portion.*

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 02)

A line graph showing mean change from baseline FEV1 (L) versus hours postdose for Clinical Trial A at Week 0 (Day 1). Two lines compare placebo and 15 mcg arformoterol tartrate inhalation solution BID. The y-axis ranges from -0.10 to 0.30 liters, and the x-axis shows hours postdose from 0 to 12. The arformoterol line shows a higher increase in FEV1 compared to placebo over time.*

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 03)

A line graph titled 'Mean Change in FEV1 Over Time for Clinical Trial A at Week 12' comparing mean change from baseline FEV1 (L) on the y-axis with hours postdose on the x-axis, from 0 to 12 hours. It shows two lines: one for placebo with minimal or negative change, and one for 15 mcg arformoterol tartrate inhalation solution BID showing a peak positive change and gradual decline over time.*

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 04)

An instructional illustration showing a person removing a protective cap from a respiratory inhalation solution ampule by twisting it off. The image focuses on the hands and the ampule, demonstrating the proper way to open it before use.*

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 05)

An instructional diagram showing a hand holding a small inhalation device above a reservoir labeled 'RESERVOIR.' The image illustrates positioning or assembly for respiratory inhalation use.*

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 06)

Illustrations labeled Figure 3 and Figure 4 showing components of a respiratory inhalation device for arformoterol tartrate solution. Figure 3 depicts a mouthpiece attachment, and Figure 4 shows an optional face mask attachment connected to the device.*

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 07)

An illustration showing a device labeled 'COMPRESSOR' with a control knob and a display window, connected to a tube labeled 'TUBING.' This image likely depicts the setup for a respiratory inhalation system using compressed air or oxygen.*

FDA Label Image

Image (2d707787 Edf5 4b8c Ba80 E83c87d47708 08)

An instructional illustration showing a person using a respiratory inhalation device by placing the mouthpiece in their mouth, demonstrating the proper method for inhalation of an aerosol solution.*

FDA Label Image

Pouch 1 Unit (2d707787 Edf5 4b8c Ba80 E83c87d47708 09)

Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL, a respiratory inhalation solution in sterile unit-dose vials. The label includes storage instructions, warnings to keep out of reach of children, and manufacturer information for Lifestar Pharma LLC.*

FDA Label Image

5s Foil (2d707787 Edf5 4b8c Ba80 E83c87d47708 10)

Label for arformoterol tartrate inhalation solution 15 mcg per 2 mL, a respiratory inhalation solution by Lifestar Pharma LLC. The label indicates four 2 mL sterile unit-dose vials per package, with storage and dosage instructions, barcode, and manufacturer information. The product is Rx only.*

FDA Label Image

30 Carton (2d707787 Edf5 4b8c Ba80 E83c87d47708 11)

Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL packaging label for respiratory inhalation use. The label states 'Rx only' and includes storage instructions to keep refrigerated or store at room temperature for up to 6 weeks. Manufactured by Lifestar Pharma LLC, the package contains 30 sterile unit-dose vials of 2 mL each. The label also notes potency expressed as arformoterol and provides directions for use and handling.*

FDA Label Image

60 (2d707787 Edf5 4b8c Ba80 E83c87d47708 12)

Label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Lifestar Pharma LLC. The product is supplied as 60 sterile unit dose vials (2 mL each) for oral inhalation only. The label includes storage instructions to keep refrigerated or room temperature for up to 6 weeks and notes potency is expressed as arformoterol. The label also displays the NDC 70756-612-60 and has manufacturer and barcode details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.